Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hershey Co (HSY) vs Oscar Health Inc (OSCR) Price & Performance

Hershey CoTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Hershey Co vs Oscar Health Inc — how do they compare? Hershey Co trades at $162.36 (market cap $32.66B), while Oscar Health Inc trades at $33.4 (market cap $10.22B). The key difference: Hershey Co is far larger — about 3.2× Oscar Health Inc's market cap, and Hershey Co pays a 3.57% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hershey Co for 135 Days and Oscar Health Inc for 15 Days on average.

HSYOSCR
Market Cap
$32.66B$10.22B
Volume
1,578,2374,123,394
Sector
Consumer StaplesHealth
52-Week High
$236.28$33.81
52-Week Low
$157.61$10.85
Typical Hold Time
135 Days15 Days
Enterprise Value
$37.79B$6.57B
Dividend Yield
3.57%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hershey Co

Hershey (HSY) trades at $161.88, up 0.96% with a bearish technical outlook. The stock shows strong profitability with 12.24% net margin and 32.81% ROE, though Q3 2026 earnings are pending. Recent news highlights brand investments and dividend resumption after a near 2-year freeze. Valuation metrics include P/E of 22.2 and P/S of 2.72, with analyst consensus price target at $204.62 representing 26% upside potential.

HSY presents a mixed investment case with strong fundamentals offset by near-term headwinds. The opportunity lies in consistent dividend growth potential and market leadership, while risks include commodity cost pressures and competitive challenges. Analyst sentiment leans cautious with 66% hold ratings, suggesting patience for earnings catalysts and margin stabilization.

Oscar Health Inc

OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.

The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hershey Co

Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.

Read more on HSY →

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →